1.Insall-Burstein Posterior Stabilized Knee Prosthesis: Preliminary Report
Dae Kyung BAE ; Young Kwon KIM ; Sang Wook BAE ; Young Ryong KIM ; Chung O KIM
The Journal of the Korean Orthopaedic Association 1983;18(6):1148-1154
No abstract available in English.
Knee Prosthesis
;
Knee
2.Leiomyosarcoma of the descending colon.
Hee Yeol BAE ; Tae Gyun KIM ; Jin Han BAE ; Bong Wha CHUNG ; Ki Chu LEE
Journal of the Korean Surgical Society 1991;41(1):130-135
No abstract available.
Colon, Descending*
;
Leiomyosarcoma*
3.A case of multiple congenital anomaly.
Chang Qyun CHUNG ; Hyun Young BAE ; Deok Rye KIM ; Yong Hae PARK ; Ho Soon CHUNG
Korean Journal of Obstetrics and Gynecology 1992;35(9):1407-1413
No abstract available.
4.Total Serum IgE Level in Each Age Group of Patients with Atopic Dermatitis.
Sung Bum KANG ; Sang Bae LEE ; Jin Wou KIM ; Jeung Kyu KIM ; Chung Won KIM
Korean Journal of Dermatology 1988;26(4):507-512
We evaluated median value and lower confidence limit of total serum IgE level in each age group of 1,493 pure atopic dermatitis patient without respiratory atopic diseases. The results were as follows . 1. The median value of total serum IgE level of each age group in patients with atopic dermatitis distributed from 56.5 IU/@Ll to 660It.J/C. The distributions of the median value of total serum IgE levels of total patients with atopic dermatitis, total male patients with atopic dermatitis, and total female patients with atopic dermatitis were 185 IU/C, 220 IUj'@C, and 165 IUj'C. There was no statistical significance of median value of total serum IgE level between mole patients and female patients. 2. The 95% and 99% lower confidence limit(one-sided) of total serum IgE level of ea.ch age group in patients with atopic dermatitis distributed from 32.6 IU /n4 to 287IU/v4 and from 31 IU/m0 to 202 IU4. The 95% lower confidence limit (one-sided) of total serum IgE level of total patients with atopic dermatitis, tatal male patients with atopic dermatitis, and. total female patients with atopic dermatitis were 170 II.J/m0, 185 IU,m/l, and 133 IUm/l. The 99% lower confidence limit.(one-sided) of total serum IgE level of total patient with atopic dermatitis, total male patient with atopic dermatitis, and total female patients with atopic dermatitis were 165 IU/ml, 180 IU/ml, and 125 IU/ml.
Dermatitis, Atopic*
;
Female
;
Humans
;
Immunoglobulin E*
;
Male
5.Common bile duct and Gall Bladder Varices: Findings of ERCP and Doppler ultrasonography.
Won Ho KIM ; Jae Bock CHUNG ; Sang In LEE ; Chae Yoon CHON ; Heung Jai CHOI ; Chung Bae KIM
Korean Journal of Gastrointestinal Endoscopy 1988;8(1):59-62
After portal vein occlusion, portal to portal collaterals (hepatopetal) develop from preexisting periportal vessels or recanalization of the thrombosed portal vein, undergo compensatory enlargement, bypass the obstructed extrahepatic occlusion and reconstitute the intrahepatic portal branches. Angiographically, collateral veins are seen as multiple tortous winding veins in the porta hepatis and are described as a cavemous transformation of the portal vein. When the common bile duct or gall bladder is compressed by collateral veins, a cholangiogram demonstrates multiple smooth intramural defects and jaundice can develop due to the partial obstruction of the bile duct. Demonstration of the cavernous transformation of the portal vein can be done by ultrasonography, abdominal computed tomography and nuclear magnetic resonance, but Doppler ultrasonography and direct or indirect portography are needed to evaluate its hemodynamic change. We present a 35-year-old female patient complaining repeated jaundice, in whom common bile duct and gall bladder varices accompanied by cavernous transformation of the portal vein and intrahepatic stones were diagnosed by ultrasonography, abdominal computed tomography, ERCP, and Doppler ultrasonograpy and confirmed by surgery. ERCP demonstrated the irregular contour of the common bile duct and gall bladder due to multiple smooth intramural defects. Doppler utrasongraphy revealed the unique flow signal of portal vasculature from the tortous vessls in the porta hepatis and from the vascular structures on the wall of the gall bladder.
Adult
;
Bile Ducts
;
Cholangiopancreatography, Endoscopic Retrograde*
;
Common Bile Duct*
;
Female
;
Hemodynamics
;
Humans
;
Jaundice
;
Magnetic Resonance Spectroscopy
;
Portal Vein
;
Portography
;
Ultrasonography
;
Ultrasonography, Doppler*
;
Urinary Bladder*
;
Varicose Veins*
;
Veins
;
Wind
6.Hypolipidemic Effects and Safety of Lovastatin in Patients with Primary Hypercholesterolemia.
Jong Hoa BAE ; Chung Whee CHOUE ; Kwon Sam KIM ; Myung Shick KIM ; Jung Sang SONG
Korean Circulation Journal 1991;21(1):129-136
To evaluate the efficacy and safety of lovastatin, new hypolipidemic agent of HMG-CoA reductase inhibitor, we administered lovastatin 40mg to 80mg once daily for 12 weeks in 20 patients(7 males, 13 females) with primary hypercholesterolemia, and observed the sequential chamges of the lipid profile every 4 weeks. The results are as follows ; 1) The seurm total cholesterol was reduced significantly by 31% from 321+/-36mg% to 210+/-26mg%(p<0.05). 2) The serum triglycerides was significantly reduced from 321+/-168mg% to 228+/-74mg% by 29%(p<0.05). 3) The low density lipoprotein cholesterol was reduced significantly from 177+/-36mg% to 120+/-22mg% by 32%(p<0.05). 4) The total lipid, high density lipoprotein cholesterol and very low density lipoprotein cholesterol were also reduced significantly. 5) The ratio between total cholesterol and high density lipoprotein cholesterol, low density lipoprotein cholesterol and high density lipoprotein cholesterol did not change after lovastatin therapy. 6) There was no adverse reaction due to lovastatin therapy during 12 weeks of therapy. These results suggested that lovastatin is a effective and safe now hypolipidemic agent and is a convenient HMG-CoA reductase inhibitor for clinical use.
Cholesterol
;
Cholesterol, HDL
;
Cholesterol, LDL
;
Cholesterol, VLDL
;
Humans
;
Hypercholesterolemia*
;
Lovastatin*
;
Male
;
Oxidoreductases
;
Triglycerides
7.A Study on the Methylation of p 16 Gene Promotor in the Uterine Cervical Neoplasia.
Dong Han BAE ; Min Kwan KIM ; Chung Il LEE ; Chang Jin KIM
Korean Journal of Obstetrics and Gynecology 2000;43(9):1525-1532
No abstract available.
Methylation*
8.Efficacy of doppler umbilical artery velocimetry in the prediction of intrauterine growth retardation and perinatal outcome.
In Bae CHUNG ; Yong Won PARK ; Tae Yoon KIM ; Yoo Kon KIM ; Tchan Kyu PARK
Korean Journal of Obstetrics and Gynecology 1991;34(1):28-34
No abstract available.
Fetal Growth Retardation*
;
Rheology*
;
Umbilical Arteries*
9.Serum Angiotensin-Coverting Enzyme Levels in Coal Worker's Pneumoconiosis.
Kyung Dong KIM ; Myung Sook CHOI ; Chae Hoon LEE ; Chung Sook KIM ; Eun Kyung BAE
Yeungnam University Journal of Medicine 1989;6(1):109-119
We measured fasting Serum Angiotensin-Converting Enzyme (SACE) in 100 healthy controls and 75 coal worker's pneumoconiosis (CWP) patients by a commercial kits (ACEcolor®, Fujirio Inc., Japan) and evaluated this manual method. The linear range extends to an activity of 80U/L. Precision on a commercial control serum (ACE control-N®, Sigma Co.) with a mean value of 9.47U/L yielded a within-run and between-run CVs are 5.6% (N=15) and 6.9% (N=14) respectively. Save in 75 CWP was 20.3±5.7U/L (mean±s.d.); higher than in healthy controls (13.4±3.9U/L, P<0.01). No correlation was found between SACE, sex, and age. The results suggest that the measurement for SACE and follow-up SACE in coal workers may be a useful diagnostic tools for CWP.
Anthracosis*
;
Coal*
;
Fasting
;
Follow-Up Studies
;
Humans
;
Methods
10.Doppler Evaluation of Left Ventricular Diastolic Filling in Patient with Hypertension.
Chung Whee CHOUE ; Kwon Sam KIM ; Myung Sik KIM ; Jung Sang SONG ; Jong Hoa BAE
Korean Circulation Journal 1987;17(4):621-626
To study left ventricular diastolic filling in patient with hypertension in different form of left ventricular hypertrophy(LVH), 105 patients with hypertension and 30 normal persons underwent M-mode echocardiography and pulsed Doppler measurement of the left ventricular inflow. From the M-mode echocardiographic measurement of left ventricular dimension, hypertensive patients were subdivided into three grouops : group I(n=27) ; no LVH, group II(n=36) ; concentric LVH, grooup III(n=42) asymmetric septal hypertrophy. From the digitized trace of the pulsed Doppler at the mitral valve level, Doppler diastolic time intervals, peak velocities at rapid filling (E velocity) and atrial contraction(A velocity) and the triangle area under the A velocity(A area) and triagle area under the E velocity(E area) were measured. The peak A velocity(normal subjects ; 0.51+/-0.08m/sec, group I ; 0.73+/-0.14m/sec, group II ; 0.78+/-0.15m/sec, group III ; 0.8+/-0.23 m/sec) and the A area(noral subjects ; 4.71+/-1.64, group I; 6.24+/-1.78, group II ; 7.75+/-2.93, group III ; 8.05+/-3.11) and the peak A/E velocity ratio and the A/E area ratio were significantly different from the normal controls(P<0.01). The peak E velocity(normal subjects ; 0.76+/-0.13, group I ; 0.7+/-0.12, group II ; 0.63+/-0.12, group III ; 0.59+/-0.15m/sec) and E area (normal subjects ; 9.61+/-2.8, group I ; 8.11+/-2.13, group II ; 7.82+/-2.73, group III ; 7.34+/-3.07) were significantly different between hypertensive groups with LVH and normal controls. Doppler time intervals, total area were not different between groups. This study shows that abnormal pattern of left ventricular diastolic filling occur in patients with hypertension and the peak A velocity and the peak A/E velocity ratio and the peak A/E area ratio are the earliest findings that can detectable by Doppler echocardiography.
Cardiomyopathy, Hypertrophic
;
Echocardiography
;
Echocardiography, Doppler
;
Humans
;
Hypertension*
;
Mitral Valve